• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

Roquinimex

Roquinimex (FCF89) 是一种喹啉衍生物免疫刺激剂，可增加 NK 细胞活性和巨噬细胞的细胞毒性，抑制血管生成并减少 TNF α 的分泌。

CAS号

84088-42-6

分子式

C18H16N2O3

主要靶点

TNF

仅限科研使用

Cat No : CM06687

Print datasheet

Synonyms

FCF89|ABR212616|Linomide|LS2616|罗喹美克

验证数据展示

  • CAS No.: 84088-42-6

    Roquinimex
    CAS#: 84088-42-6

产品信息

Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.

CAS号 84088-42-6
分子式 C18H16N2O3
主要靶点 TNF
主要通路 凋亡
分子量 308.34
纯度 99.65%， 此纯度可做参考，具体纯度与批次有关系，可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year
别名 FCF89|ABR212616|Linomide|LS2616|罗喹美克

溶解度

DMSO:83.3 mg/mL (270.17 mM)

参考文献

1.Liu Q,etal. Roquinimex inhibits dextran sodium sulfate-induced murine colitis.Inflamm Res. 2003 Feb;52(2):64-8.
2.Tian WZ,etal.Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis.Acta Neurol Scand. 1998 Aug;98(2):94-101.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2